Skip to main content

Table 2 Effect of silymarin on serum and liver lipid profile

From: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

Group Lipid Profile of Rats
LDL-C (mg/dl) TC (mg/dl) HDL-C (mg/dl) S-TG (mg/dl) H-TG (mmol/g)
NC 5.50 ± 2.43 39.00 ± 4.77 17.00 ± 2.28 39.17 ± 5.52 0.5 ± 0.01
FC 9.00 ± 2.37* 53.83 ± 7.91* 12.17 ± 3.54 57.83 ± 8.10** 0.57 ± 0.03***
SC 6.00 ± 1.79 42.50 ± 6.95 15.83 ± 3.31 42.83 ± 6.05 ## 0.52 ± 0.01 ###
FTH 6.83 ± 1.94 50.67 ± 7.89 12.67 ± 3.08 45.50 ± 9.65 # 0.54 ± 0.02 #
FFH 6.67 ± 1.21 48.50 ± 10.84 15.33 ± 2.58 44.17 ± 4.96 # 0.53 ± 0.02 #
  1. At the end of the experiment serum and liver lipid profile were measured. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. * p < 0.05 vs. NC; ** p < 0.01 vs. NC; *** p < 0.001 vs. NC and # p < 0.05 vs. FC; ## p < 0.01 vs. FC; ### p < 0.001 vs. FC